Fragile Syndrome
📧 Sign up to get email alerts when something new happens for Fragile Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome [Phase 2]
Phase 2 trial evaluated AFQ056 (mavoglurant) for safety and efficacy in adolescents with Fragile X syndrome; results were posted in 2015 aft…
-
CLINICAL_TRIALS trial_result · 2015-04-14Clinical Trial Update: Safety and Efficacy Study of Antioxidants for the Treatment of the Fragile X Syndrome [Phase 2]
Phase 2 safety and efficacy study of antioxidants for Fragile X syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: Double-blind Placebo Controlled Study of Oxytocin in Fragile X Syndrome [Phase 2]
Phase 2 double-blind, placebo-controlled trial of oxytocin in Fragile X Syndrome completed with posted results.
-
CLINICAL_TRIALS trial_result · 2014-07-30Clinical Trial Update: Trial of Minocycline to Treat Children With Fragile X Syndrome [NA]
The clinical trial testing minocycline in children with Fragile X Syndrome has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2013-07-31Clinical Trial Update: Efficacy and Safety Study of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Children With Fragile X Syndrome [Phase 3]
This clinical trial update reports on the efficacy and safety of arbaclofen (STX209) for treating social withdrawal in children with Fragile…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-31Clinical Trial Update: Efficacy and Safety Study of STX209 (Arbaclofen) for Social Withdrawal in Adolescents and Adults With Fragile X Syndrome [Phase 3]
Phase 3 efficacy and safety study of arbaclofen (STX209) for social withdrawal in adolescents and adults with Fragile X syndrome has complet…
-
CLINICAL_TRIALS trial_result · 2013-07-31Clinical Trial Update: An Open Label Extension Study in Subjects With Fragile X Syndrome [Phase 3]
An open-label extension study in Fragile X syndrome (Phase 3) has been terminated; the document provides the current status of the trial.
-
CLINICAL_TRIALS research · 2013-07-31Clinical Trial Update: Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001
This clinical trial update documents biomarker testing and DNA collection procedures for subjects enrolled in Protocol 22001 for Fragile X S…
-
CLINICAL_TRIALS research · 2013-07-31Clinical Trial Update: Biomarker and DNA Collection in Subjects Participating in Protocol 22003
Clinical trial update for Protocol 22003 notes biomarker collection and DNA sampling in subjects with Fragile X syndrome; the study status i…
-
CLINICAL_TRIALS trial_result · 2013-05-06Clinical Trial Update: Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome [Phase 2]
A Phase 2 safety, tolerability and efficacy study of STX209 (arbaclofen) in Fragile X syndrome has completed with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2012-12-20Clinical Trial Update: An Open Label Extension Study of STX209 in Subjects With Fragile X Syndrome [Phase 2]
Open-label extension study of STX209 (arbaclofen) in Fragile X syndrome in Phase 2 has been terminated.
-
CLINICAL_TRIALS other · 2012-12-20Clinical Trial Update: A Study to Assess the Tolerability of a Single Dose of STX107 in Adults With Fragile X Syndrome [Phase 2]
A Phase 2 tolerability study of STX107 in adults with Fragile X Syndrome has been suspended, providing a status update on the trial.
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: An Open-Label Trial of Donepezil in Fragile X Syndrome [Phase 1]
Open-label Phase 1 trial evaluating donepezil for Fragile X Syndrome has completed at Stanford University.
-
CLINICAL_TRIALS trial_result · 2012-06-12Clinical Trial Update: Validation of Saliva in the Esoterix Genetic Laboratories Fragile X Assay
This document provides an update on validating a saliva-based Fragile X assay developed by Esoterix Genetic Laboratories. The study aims to …
-
CLINICAL_TRIALS trial_result · 2012-04-27Clinical Trial Update: Open Label Study Investigating Safety and Efficacy of NPL2009 50 mg - 150 mg on Prepulse Inhibition Tests and Continuous Performance Tasks, Adults With Fragile X Syndrome [Phase 1, Phase 2]
An open-label Phase 1/2 study evaluated the safety and potential efficacy of NPL2009 at 50-150 mg in adults with Fragile X Syndrome. The tri…
-
CLINICAL_TRIALS trial_result · 2010-02-08Clinical Trial Update: A Single-Dose Study in Normal Volunteers to Assess the Safety, Tolerability and Pharmacokinetics of STX107 [Phase 1]
Phase 1 single-dose study in healthy volunteers to evaluate the safety, tolerability, and pharmacokinetics of STX107; the trial has complete…